Noteworthy - July/August 2023

August 10, 2023 Providence inScope Content Team

Providence St. Vincent receives sixth Magnet designation
Congratulations to Providence St. Vincent Medical Center for achieving Magnet recognition six consecutive times, reinforcing the hospital’s commitment to nursing excellence and to its patients. This redesignation makes Providence St. Vincent the 12th hospital in the world and the only one in the Providence system to obtain Magnet designation six times. Magnet recognition is the highest national honor for professional nursing practice. Providence St. Vincent first attained primary designation in 2000.

Join us Aug. 13 for Providence Bridge Pedal and Stride
Cyclists of all abilities and walkers can enjoy Portland’s iconic bridges without cars during this beloved community tradition. This year’s event will be held Sunday, Aug. 13 and will include a celebration of the Fremont Bridge, which turns 50 this year. Enjoy unparalleled views from the top deck of the Fremont Bridge, as well as the Marquam, Hawthorne, Morrison, Ross Island and Steel bridges. For those who prefer to walk, Providence Bridge Stride is a 5-mile walk crossing the Fremont and Steel bridges.

For more information and to register: https://www.providence.org/lp/bridge-pedal

Providence’s cardio-oncology program wins award
The Providence Jack Loacker Center for Cardio-Oncology was awarded a Silver Center of Excellence Award through the International Cardio-Oncology Society. The program is the first in Oregon and only the third program west of the Mississippi to receive this recognition. The program signifies an exceptionally high concentration of expertise and related resources delivering care in a comprehensive, interdisciplinary fashion to afford the best patient outcomes possible.

Providence Cancer Institute researchers participate in international meeting
Earlier this summer, oncology professionals from around the world gathered at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Providence Cancer Institute researchers attended, contributing to more than 20 studies selected for presentation in poster sessions, poster discussions, an oral abstract session and a plenary session.

Providence Cancer Institute welcomes five new providers
Welcome to five new Providence Cancer Institute providers, all of whom welcome referrals:

Eric C. Anderson, M.D., Ph.D.
Medical oncology/hematology
Providence Hood River Memorial Hospital Cancer
Asher Caldwell, MSN, ANP-BC, ACHPN
Palliative care
Providence Cancer Institute Franz Clinic
Evie Hobbs, M.D.
Breast oncology
Providence Cancer Institute Oncology & Hematology Care Clinic – Westside
Zoe Holman, Lac
Acupuncture
Bradley J. Stuvland Integrative Medicine Clinic
Zidell Center for Integrative Medicine
Caleb Langsam, PA-C
Dysplasia
Franz Dysplasia Clinic

About the Author

The inScope content team focuses on bringing you the latest in clinical news from our team of world-class medical providers and physician leaders.
More Content by Providence inScope Content Team

Welcome to your journey for creating a healthier you

Noteworthy - July/August 2023

About the Author

Previous Article

Next Article

Noteworthy - July/August 2023

About the Author

Previous Article

Next Article

Most Recent Articles

What is required to make clinical trials accessible to people in Hood River and other Columbia Gorge communities? Learn more about why it's important to expand access to studies and cancer care.

This prestigious award recognizes Dr. Fox’s extraordinary contributions to the field of immunotherapy and his lifelong dedication to advancing cancer research.

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes.

Years after the start of the pandemic, more than 200 patients continue to be cared for at Providence for ongoing symptoms that remain from contracting COVID-19. Learn how Providence continues helping.

A new investigator-initiated study for patients with metastatic melanoma and HNSCC aims to evaluate a galectin-3 inhibitor as a way to “remove the brakes” from the immune system.

The advent of MRI scanning of the brain and spinal cord was a giant leap forward in improving the ability to diagnose multiple sclerosis with greater sensitivity and reliability.

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.

During winter months when the days are shorter and darker, both postpartum depression and baby blues may be more difficult.

A study led by Dr. Christopher Darus may offer hope to women with persistent endometrial cancer. Currently, the prognosis is poor for women with this form of cancer.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Being able to assess the level of fibrosis and make appropriate referrals is important in the care of patients with Steatotic Liver Disease (formerly known as Fatty Liver).

The regional pharmacy team regularly updates its Pathway to Treat tool for providers, helping to guide evidence-based care.

Providence Portland Medical Center announced it will expand its emergency department to meet the growing demands of our community.